Preclinical CRO Market Size, Revenue Share, Growth Factors, Trends, Analysis & Forecast Till 2030
Preclinical CRO Market Insights:
In a recent research report by Market
Research Community, the preclinical CRO market is expected to surpass USD 8.82 Billion
by the year 2030, from USD 4.60 Billion in 2021.
A preclinical
contract research organization (CRO) is a
company that provides services to support the preclinical development of
pharmaceuticals, medical devices, and other products. Preclinical development
refers to the early stages of product development, during which the safety and
effectiveness of a product is tested in a laboratory or animal model before it
is tested in humans. Preclinical CROs offer a range of services, including testing
products in cell and animal models, conducting toxicology studies, and
providing data analysis and reporting.
Preclinical CROs provide support to
biopharmaceutical and medical device companies by taking on some of the tasks
and responsibilities involved in the early stages of product development. This
allows the companies to focus on their core business activities, such as
research and development, manufacturing, and marketing, while the CRO handles
the preclinical testing and data analysis. Preclinical CROs offer a range of
services, including:
·
Testing products in cell and animal models to assess
their safety and effectiveness
·
Conducting toxicology studies to evaluate the
potential risks and side effects of a product
·
Providing data analysis and reporting to help
clients understand the results of their studies
The preclinical CRO market is projected to grow at a
significant pace reaching a CAGR of approximately 7.5%, over the forecast
period of 2022–2030, despite a considerable fall in Service sales during the
initial phase of pandemic spread and lockdown restrictions imposed globally.
Get
your sample report here: https://marketresearchcommunity.com/sample-request/?rid=782
Segment:
By
Service
·
Bioanalysis and DMPK studies
·
Toxicology Testing
·
Compound Management
·
Chemistry
·
Safety Pharmacology
·
Other
By
Model Type
·
Patient-Derived Organoid (PDO) Model
·
Patient-derived xenograft model
By
end-use
·
Biopharmaceutical Companies
·
Government and Academic Institutes
·
Medical Device Companies
The study is consolidated into major segments and
further into sub-segments, such as by Service (Bioanalysis and DMPK studies, Toxicology Testing, Compound Management, Chemistry, Safety
Pharmacology, Others) by Model Type (Patient-Derived Organoid (PDO) Model, Patient-derived
xenograft model), by end-use (Biopharmaceutical Companies, Government and
Academic Institutes, Medical Device Companies) to forecast the market size by
value; also includes the analysis of past market dynamics from 2016 – 2021,
considering 2021 as the base year.
Lastly, the Preclinical
CRO Market Share report includes a regional analysis and country analysis
with the latest trends, along with the major key players including Alexion
Pharmaceutical Inc., Grifols SA, and Avadel Pharmaceuticals plc. Novartis AG,
Pfizer, Inc., AbbVie Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc,
Bausch Health Companies Inc., and Shire plc. Alexion Pharmaceuticals and
Astellas Pharma
Contact:
Market Research Community
+44–20–8133–9198
sales@marketresearchcommunity.com
Market Research Community is
the leading research industry that offers contextual and data-centric research
services to its customers across the globe. The firm assists its clients to
strategize business policies and accomplish sustainable growth in their
respective market domain.
Comments
Post a Comment